BVXV Stock Forecast and Price Target (BiondVax Pharmaceuticals Ltd. stock)

BVXV Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -18.95% during the next 3 months and, with a 90% probability hold a price between $1.58 and $2.46 at the end of this 3-month period.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-20	$1.94	$2.48	$3.02
2021-09-21	$1.92	$2.47	$3.01
2021-09-22	$1.91	$2.46	$3.00
2021-09-23	$1.90	$2.45	$2.99
2021-09-24	$1.89	$2.43	$2.98
2021-09-27	$1.88	$2.42	$2.97
2021-09-28	$1.87	$2.41	$2.96
2021-09-29	$1.86	$2.40	$2.94
2021-09-30	$1.85	$2.39	$2.93
2021-10-01	$1.83	$2.38	$2.92
2021-10-04	$1.82	$2.37	$2.91
2021-10-05	$1.81	$2.36	$2.90
2021-10-06	$1.80	$2.34	$2.89
2021-10-07	$1.79	$2.33	$2.88
2021-10-08	$1.78	$2.32	$2.87
2021-10-11	$1.77	$2.31	$2.85
2021-10-12	$1.76	$2.30	$2.84
2021-10-13	$1.74	$2.29	$2.83
2021-10-14	$1.73	$2.28	$2.82
2021-10-15	$1.72	$2.27	$2.81
2021-10-18	$1.71	$2.25	$2.80
2021-10-19	$1.70	$2.24	$2.79
2021-10-20	$1.69	$2.23	$2.78
2021-10-21	$1.68	$2.22	$2.76
2021-10-22	$1.67	$2.21	$2.75
2021-10-25	$1.65	$2.20	$2.74
2021-10-26	$1.64	$2.19	$2.73
2021-10-27	$1.63	$2.18	$2.72
2021-10-28	$1.62	$2.16	$2.71
2021-10-29	$1.61	$2.15	$2.70

About BiondVax Pharmaceuticals Ltd.

Biondvax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company, focuses on developing and commercializing immunomodulation therapies for infectious diseases primarily in Israel. The company offers M-001, a synthetic peptide-based protein, which is in Phase 2 clinical development stage targeting seasonal and pandemic strains of the influenza virus. Biondvax Pharmaceuticals Ltd. was founded in 2003 and is based in Ness Ziona, Israel.... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!